This article was originally published in Clinica
The EU now includes 25 countries and almost half a billion citizens, so there has never been a better time to maximise your product development processes against the competition. This course will help you understand the European clinical trial process for medical devices, writes Daniel Barry.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.